Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

Year Published

The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role Of Lrrk2 and Alpha-Synuclein Genes in Parkinson's Disease

January 15, 2008

NEWYORK, NY—The Michael J. Fox Foundation for Parkinson’s Research today announced approximately $2 million in total funding for seven research studies aiming to advance the ability of the Parkinson…

Learn more
Intel Co-Founder Andrew S. Grove Dedicates Portion of his Estate, up to $40 Million, to Michael J. Fox Foundation

January 10, 2008

NEWYORK, NY — Andrew S. Grove, co-founder of technology giant Intel and senior advisor to The Michael J. Fox Foundation for Parkinson’s Research, announced his intent to bequeath a portion of his…

Learn more
Michael J. Fox Foundation Awards $2 Million to Continue Search for Biomarkers of Parkinson’s Disease

December 19, 2007

NEWYORK, NY— The Michael J. Fox Foundation today announced $2 million in grants awarded under the third round of Biomarkers, its annual funding program dedicated to developing objective biomarkers,…

Learn more
Michael J. Fox Foundation Awards $4.4 Million for Development of New Class of Parkinson’s Therapy

December 18, 2007

NEWYORK, NY — The Michael J. Fox Foundation has awarded $4.4 million to jump-start the development of a new class of symptomatic Parkinson’s disease drugs targeting glutamate receptor mGluR4…

Learn more
Katie Hood Appointed Chief Executive Officer of The Michael J. Fox Foundation

December 14, 2007

NEW YORK, NY— The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today announced the appointment of Katie Hood as chief executive officer.Ms. Hood, who joined the Foundation in…

Learn more
Mjff and Merck Serono (EMD Serono In North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders

December 13, 2007

NEWYORK, NY— The Michael J. Fox Foundation for Parkinson’s Research has committed up to $2 million for research toward therapies to alleviate Parkinson’s-related cognitive dysfunction and mood…

Learn more
Five Clinical Studies to Receive $2.5 Million Under Foundation’s 2007 Clinical Discovery Program

December 4, 2007

NEWYORK, NY— The Michael J. Fox Foundation for Parkinson’s Research today announced approximately $2.5 million in total funding for five clinical research studies under its 2007 Clinical Discovery…

Learn more

Press Releases

The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role Of Lrrk2 and Alpha-Synuclein Genes in Parkinson's Disease

Intel Co-Founder Andrew S. Grove Dedicates Portion of his Estate, up to $40 Million, to Michael J. Fox Foundation

Michael J. Fox Foundation Awards $2 Million to Continue Search for Biomarkers of Parkinson’s Disease

Michael J. Fox Foundation Awards $4.4 Million for Development of New Class of Parkinson’s Therapy

Katie Hood Appointed Chief Executive Officer of The Michael J. Fox Foundation

Mjff and Merck Serono (EMD Serono In North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders

Five Clinical Studies to Receive $2.5 Million Under Foundation’s 2007 Clinical Discovery Program